1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Liangjing Lu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis Relma-cel - Systemic Sclerosis | Phase 1 | Recruiting | Liangjing Lu | 6 | 2024-06-12 | 2024-08-15 |
China (1)